Aridis Pharmaceuticals, Inc. (ARDS) Earnings
|
Expand Research on ARDS
| Next EPS Date | 6/12/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +24.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -6.6% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
6/12/26  |
Q126 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/25/26 |
Q425 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/25/25 |
Q325 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/24/25 |
Q325 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/3/25 |
Q325 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/5/25 |
Q325 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/7/25 |
Q325 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/10/25 |
Q325 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
